Peili Bu

2.3k total citations
64 papers, 1.7k citations indexed

About

Peili Bu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Peili Bu has authored 64 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 21 papers in Cardiology and Cardiovascular Medicine and 13 papers in Geriatrics and Gerontology. Recurrent topics in Peili Bu's work include Sirtuins and Resveratrol in Medicine (13 papers), Atherosclerosis and Cardiovascular Diseases (8 papers) and Cardiac Fibrosis and Remodeling (8 papers). Peili Bu is often cited by papers focused on Sirtuins and Resveratrol in Medicine (13 papers), Atherosclerosis and Cardiovascular Diseases (8 papers) and Cardiac Fibrosis and Remodeling (8 papers). Peili Bu collaborates with scholars based in China, Thailand and United States. Peili Bu's co-authors include Tongshuai Chen, Yun Zhang, Junni Liu, Yun Zhang, Yi Yang, Jingyuan Li, Na Li, Shujian Wang, Xuefang Yan and Jingyuan Li and has published in prestigious journals such as Nature Communications, PLoS ONE and Circulation Research.

In The Last Decade

Peili Bu

62 papers receiving 1.6k citations

Peers

Peili Bu
Peili Bu
Citations per year, relative to Peili Bu Peili Bu (= 1×) peers Takeshi Kanda

Countries citing papers authored by Peili Bu

Since Specialization
Citations

This map shows the geographic impact of Peili Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peili Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peili Bu more than expected).

Fields of papers citing papers by Peili Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peili Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peili Bu. The network helps show where Peili Bu may publish in the future.

Co-authorship network of co-authors of Peili Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Peili Bu. A scholar is included among the top collaborators of Peili Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peili Bu. Peili Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yuan, Chunmei Zhang, Chen Zhang, et al.. (2025). SIRT3 suppresses vascular endothelial senescence via DHRS2 and contributes to the anti-vascular aging effect of Bazi Bushen capsule. Phytomedicine. 140. 156571–156571. 1 indexed citations
3.
Hu, Yang, Yun Ti, Binghui Kong, et al.. (2025). Adipose ZFP36 protects against diet-induced obesity and insulin resistance. Metabolism. 164. 156131–156131. 3 indexed citations
4.
Xue, Fei, Cheng Cheng, Wenhai Sui, et al.. (2024). Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis. Signal Transduction and Targeted Therapy. 9(1). 273–273. 16 indexed citations
5.
Liu, Jing, et al.. (2023). Fibulin7 Mediated Pathological Cardiac Remodeling through EGFR Binding and EGFR‐Dependent FAK/AKT Signaling Activation. Advanced Science. 10(24). e2207631–e2207631. 21 indexed citations
6.
Chen, Zhen, Peng Xia, Chunmei Zhang, et al.. (2022). Giant Paraganglioma Complicated With Catecholamine Crisis and Catecholamine Cardiomyopathy: A Case Report and Review of the Literature. Frontiers in Endocrinology. 12. 790080–790080. 3 indexed citations
7.
Zhang, Yuan, Wenzhao Liu, Zhen Chen, et al.. (2022). Value of the Systemic Immune-Inflammatory Index (SII) in Predicting the Prognosis of Patients With Peripartum Cardiomyopathy. Frontiers in Cardiovascular Medicine. 9. 811079–811079. 17 indexed citations
8.
Qi, Yan, Chunmei Zhang, Xuefang Yan, et al.. (2022). SS31 Alleviates Pressure Overload-Induced Heart Failure Caused by Sirt3-Mediated Mitochondrial Fusion. Frontiers in Cardiovascular Medicine. 9. 858594–858594. 16 indexed citations
9.
Zhang, Chunmei, Yan Qi, Chen Zhang, et al.. (2021). Melatonin Alleviates Contrast‐Induced Acute Kidney Injury by Activation of Sirt3. Oxidative Medicine and Cellular Longevity. 2021(1). 6668887–6668887. 46 indexed citations
10.
Chen, Tongshuai, Chang Ma, Hui Liu, et al.. (2020). SIRT3 protects endothelial cells from high glucose-induced senescence and dysfunction via the p53 pathway. Life Sciences. 264. 118724–118724. 37 indexed citations
11.
Ma, Chang, Tongshuai Chen, Yun Ti, et al.. (2020). Ranolazine alleviates contrast-associated acute kidney injury through modulation of calcium independent oxidative stress and apoptosis. Life Sciences. 267. 118920–118920. 9 indexed citations
12.
Yang, Yi, Na Li, Tongshuai Chen, et al.. (2019). Sirt3 promotes sensitivity to sunitinib-induced cardiotoxicity via inhibition of GTSP1/JNK/autophagy pathway in vivo and in vitro. Archives of Toxicology. 93(11). 3249–3260. 30 indexed citations
13.
Zhang, Qinghai, Xun Liu, Na Li, et al.. (2018). Sirtuin 3 deficiency aggravates contrast-induced acute kidney injury. Journal of Translational Medicine. 16(1). 313–313. 33 indexed citations
14.
Guo, Xiaobin, Jingyuan Li, Yi Yang, et al.. (2017). SIRT3 inhibits Ang II-induced transdifferentiation of cardiac fibroblasts through β-catenin/PPAR-γ signaling. Life Sciences. 186. 111–117. 33 indexed citations
15.
Yang, Yi & Peili Bu. (2016). Progress on the cardiotoxicity of sunitinib: Prognostic significance, mechanism and protective therapies. Chemico-Biological Interactions. 257. 125–131. 28 indexed citations
16.
Chen, Tongshuai, Junni Liu, Shujian Wang, et al.. (2015). Mouse SIRT3 Attenuates Hypertrophy-Related Lipid Accumulation in the Heart through the Deacetylation of LCAD. PLoS ONE. 10(3). e0118909–e0118909. 106 indexed citations
17.
Ti, Yun, et al.. (2013). Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome. Clinical Nutrition. 32(5). 849–854. 16 indexed citations
18.
Li, Xiaoxing, Yuguo Chen, Haiqing Gao, et al.. (2012). Simvastatin exerts cardioprotective effects and inhibits the activity of Rho‐associated protein kinase in rats with metabolic syndrome. Clinical and Experimental Pharmacology and Physiology. 39(9). 759–764. 7 indexed citations
19.
Ma, Weihong, Yimeng Du, Yibiao Wang, et al.. (2012). Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension. BMC Cardiovascular Disorders. 12(1). 35–35. 28 indexed citations
20.
Li, Xiaoxing, Yuguo Chen, Cheng Zhang, et al.. (2008). Effects and mechanisms of PPARα activator fenofibrate on myocardial remodelling in hypertension. Journal of Cellular and Molecular Medicine. 13(11-12). 4444–4452. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026